Clinical outcomes and patient satisfaction of a pharmacist-managed, emergency department-based outpatient treatment program for venous thromboembolic disease

Canadian Journal of Emergency Medicine

Volumn 10, Issue 1, 2008, Pages 10-16

  Zed, Peter J ^a,c   Filiatrault, Lyne ^b,d  

^a QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Anticoagulation; Deep vein thrombosis; Emergency department; Outpatient; Pharmacist; Pulmonary embolism

Indexed keywords

ANTICOAGULANT AGENT; DALTEPARIN; LOW MOLECULAR WEIGHT HEPARIN; TINZAPARIN; WARFARIN;

AGED; ARTICLE; BLEEDING; CANADA; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; EMERGENCY CARE; EPISTAXIS; FEMALE; GINGIVA BLEEDING; HEALTH PROGRAM; HEMATURIA; HUMAN; INJECTION SITE BLEEDING; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; OUTCOME ASSESSMENT; OUTPATIENT; PATIENT SAFETY; PATIENT SATISFACTION; PHARMACIST; PHARMACIST MANAGED CARE; PROSPECTIVE STUDY; RECURRENT DISEASE; THROMBOCYTOPENIA; VENOUS THROMBOEMBOLISM; AMBULATORY CARE; EMERGENCY HEALTH SERVICE; HOSPITAL PHARMACY; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; THROMBOEMBOLISM;

AMBULATORY CARE; ANTICOAGULANTS; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PHARMACY SERVICE, HOSPITAL; THROMBOEMBOLISM;

EID: 47249146996     PISSN: 14818035     EISSN: 14818035     Source Type: Journal    
DOI: 10.1017/s1481803500009957     Document Type: Article

References (29)

1. White RH. The epidemiology of venous thromboembolism. Circulation 2003;107(Suppl):I4-8.
2. Silverstein MD, Heit JA, Mohr DN, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998;158:585-93.
3. Hyers TM, Hull RD, Weg JG. Antithrombotic therapy for venous thromboembolic disease. Chest 1995;108(4 suppl):335S-51S.
4. Weinman EE, Salzman EW. Deep-vein thrombosis. N Engl J Med 1994;331:1630-41.
5. Hirsh J, Levine MN. Low molecular weight heparin. Blood 1992;79:1-17.
6. Weitz JI. Low-molecular-weight heparins. N Engl J Med 1997; 337:688-98.
7. Koopman MMW, Prandoni P, Piovella F, et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular weight heparin administered at home. N Engl J Med 1996;334:682-7.
8. Levine M, Gent M, Hirsch J, et al. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 1996;334:677-81.
9. Boccalon H, Elias A, Chale J, et al. Clinical outcomes and cost of hospital vs home treatment of proximal vein thrombosis with low-molecular-weight heparin. Arch Intern Med 2000;160: 1769-73.
10. Dolovich LR, Ginsberg JS, Douketis JD, et al. A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism. Arch Intern Med 2000;160:181-8.
11. Boucher M, Rodger M, Johnson JA, et al. Shifting form inpatient to outpatient treatment of deep vein thrombosis in a tertiary care center: a cost-minimization analysis. Pharmacotherapy 2003;23:301-9.
12. Segal JB, Bolger DT, Jenckes MW, et al. Outpatient therapy with low molecular weight heparin for the treatment of venous thromboembolism: a review of efficacy, safety and costs. Am J Med 2003;115:298-308.
13. Wells PS, Kovacs MJ, Bormanis J, et al. Expanding the eligibility for outpatient treatment of deep vein thrombosis and pulmonary embolism with low-molecular-weight heparin. Arch Intern Med 1998;158:1809-12.
14. Chiquette E, Amato MG, Bussey HL. Comparison of an anticoagulation clinic with usual medical care. Arch Intern Med 1998; 158:1641-7.
15. Vinson DR, Berman DA. Outpatient treatment of deep vein thrombosis: a clinical care pathway managed by the emergency department. Ann Emerg Med 2001;37:251-8.
16. Dager WE, King JH, Branch JM, et al. Tinzaparin in outpatients with pulmonary embolism and deep vein thrombosis. Ann Pharmacother 2005;39:1182-7.
17. Vinson DR, Berman DR, Patel PB, et al. Outpatient management of deep venous thrombosis: 2 models of integrated care. Am J Manag Care 2006;12:405-10.
18. Innes GD, Dillon EC, Holmes A. Low-molecular-weight heparin in the emergency department treatment of venous thromboembolism. J Emerg Med 1997;15:563-6.
19. Kovacs MJ, Anderson D, Morrow B, et al. Outpatient treatment of pulmonary embolism with dalteparin. Thromb Haemost 2000;83:209-11.
20. Leong WA. Outpatient deep vein thrombosis treatment models. Pharmacotherapy 1998;18:170S-4S.
21. Willey ML, Chagan L, Sisca TS, et al. A pharmacist-managed anticoagulation clinic: six-year assessment of patient outcomes. Am J Health Syst Pharm 2003;60:1033-7.
22. Gray DR, Garabedian-Ruffalo SM, Chretian SD. Cost-justification of a pharmacist managed anticoagulation clinic. Ann Pharmacother 2007;41:496-501.
23. Poon IO, Lal L, Brown EN, et al. The impact of pharmacist-managed oral anticoagulation therapy in older veterans. J Clin Pham Ther 2007;32:21-9.
24. Locke C, Ravnan SL, Patel R, et al. Reduction in warfarin adverse events requiring patient hospitalization after implementation of a pharmacist-managed anticoagulation service. Pharmacotherapy 2005;25:685-9.
25. Witt DM, Sadler MA, Shanahan RL, et al. Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy. Chest 2005;127:1515-22.
26. Buller HR, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease. The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004; 126(Suppl):401S-28S.
27. Hull RD, Raskob GE, Pineo GF, et al. Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis. N Engl J Med 1992;326:975-82.
28. Harrison L, McGinnis J, Crowther M, et al. Assessment of out-patient treatment of deep-vein thrombosis with low-molecular-weight heparin. Arch Intern Med 1998;158:2001-3.
29. Wells PS, Anderson DR, Rodger MA, et al. A randomized trial comparing 2 low molecular weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism. Arch Intern Med 2005;165:733-8.